Non-hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Non-hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-11-25Clinical Trial Update: Study With Palonosetron Alone in Preventing Chemotherapy-induced Nausea and Vomiting in Untreated Patients With Aggressive Non Hodgkin's Lymphomas Who Underwent Moderately Emetogenic Chemotherapy [Phase 2]
Phase 2 study evaluating palonosetron alone for preventing chemotherapy-induced nausea and vomiting in untreated patients with aggressive no…
-
CLINICAL_TRIALS trial_result · 2009-11-02Clinical Trial Update: Amifostine for Head and Neck Irradiation in Lymphoma [Phase 2]
Phase 2 trial update evaluating amifostine to protect normal tissues during head and neck irradiation in patients with lymphoma. The study i…
-
CLINICAL_TRIALS trial_result · 2009-10-20Clinical Trial Update: Effect of Rituximab on Immunological Recall Response to Specific Antigens in the Treatment of Non-Hodgkin's Lymphoma [Phase 4]
Phase 4 clinical trial evaluating Rituxan (rituximab) for its effect on immunological recall responses to specific antigens in patients with…
-
FDA approval · 2009-10-16FDA Approved: RITUXAN — Supplemental Application (Genentech, Inc.)
FDA approved a supplemental application for Rituxan (rituximab) from Genentech.
-
CLINICAL_TRIALS trial_result · 2009-10-14Clinical Trial Update: Bortezomib and CHOP in Patients With Advanced Stage Aggressive T Cell or Natural Killer (NK)/T Cell Lymphomas [Phase 1, Phase 2]
A completed Phase 1/2 clinical study evaluated combining bortezomib with CHOP chemotherapy in patients with advanced aggressive T-cell lymph…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2009-09-30Clinical Trial Update: Rituxan Plus FavId (Idiotype Vaccine) for Low-grade Non-Hodgkin's Lymphoma [Phase 2]
This update describes a Phase 2 trial evaluating Rituxan plus FavId idiotype vaccine for low-grade non-Hodgkin lymphoma. The current status …
-
CLINICAL_TRIALS trial_result · 2009-09-24Clinical Trial Update: Phase I, Open-label, Dose-escalation, Safety and PK Study of AZD4877 [Phase 1]
A Phase I open-label, dose-escalation study of AZD4877 in lymphoma and Non-Hodgkin lymphoma was terminated.
-
CLINICAL_TRIALS trial_result · 2009-09-18Clinical Trial Update: Fludarabine,Cyclophosphamide and Rituximab Followed by Zevalin for Non-Follicular Indolent Lymphomas. [Phase 2]
Phase 2 trial evaluating Fludarabine, Cyclophosphamide, and Rituximab followed by Zevalin in indolent non-Hodgkin lymphoma; the study status…
-
CLINICAL_TRIALS research · 2009-09-15Clinical Trial Update: Intensification Therapy of Mature B-ALL, Burkitt and Burkitt Like and Other High Grade Non-Hodgkin's Lymphoma in Adults [Phase 4]
Provides an update on a Phase 4 clinical trial evaluating intensified therapy for adults with mature B-cell acute lymphoblastic leukemia, Bu…
-
FDA approval · 2009-09-03FDA Approved: ZEVALIN — Supplemental Application (Acrotech Biopharma Inc)
The FDA approved a supplemental application for ZEVALIN (ibritumomab tiuxetan) submitted by Acrotech Biopharma Inc. This action updates ZEVA…
-
CLINICAL_TRIALS trial_result · 2009-08-26Clinical Trial Update: Avastin Plus Rituximab for Patients With B-Cell Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial evaluating bevacizumab (Avastin) in combination with rituximab for patients with B-cell non-Hodgkin lymphoma has completed wit…
-
CLINICAL_TRIALS trial_result · 2009-08-18Clinical Trial Update: T-cell and B-cell Depletion in Allogeneic Peripheral Blood Stem Cell Transplantation [Phase 3]
A Phase 3 trial investigating T-cell and B-cell depletion in allogeneic peripheral blood stem cell transplantation has been terminated.
-
CLINICAL_TRIALS trial_result · 2009-07-22Clinical Trial Update: Phase II Study of Combined Modality Treatment in Primary Testicular Non-Hodgkin's Lymphoma [Phase 2]
A completed Phase II study evaluating a combined modality treatment for primary testicular non-Hodgkin lymphoma (B-cell lymphoma).
-
CLINICAL_TRIALS trial_result · 2009-07-20Clinical Trial Update: Treatment for Subjects With Non-Hodgkin's Lymphoma [Phase 2]
A Phase 2 study evaluating a treatment for Non-Hodgkin lymphoma sponsored by Amgen has completed.
-
CLINICAL_TRIALS trial_result · 2009-07-07Clinical Trial Update: G-CSF Versus G-CSF Plus GM-CSF for Stem Cell Mobilization in NHL Patients [Phase 2]
Phase 2 trial in non-Hodgkin lymphoma comparing G-CSF alone to G-CSF plus GM-CSF for stem cell mobilization; results were posted in 2009.
-
CLINICAL_TRIALS trial_result · 2009-07-07Clinical Trial Update: Pixantrone, Cytarabine, Methylprednisolone, and Cisplatin in Treating Patients With Aggressive Non-Hodgkin's Lymphoma in First Relapse [Phase 2]
This is a Phase 2 trial evaluating a four-drug regimen (pixantrone, cytarabine, methylprednisolone, and cisplatin) for aggressive non-Hodgki…
-
CLINICAL_TRIALS research · 2009-07-07Clinical Trial Update: Combination Chemotherapy in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma [Phase 1]
This document provides an update on a Phase 1 clinical trial evaluating combination chemotherapy for patients with relapsed or refractory ag…
-
CLINICAL_TRIALS trial_result · 2009-06-04Clinical Trial Update: Study of TPI 287 in Patients With Advanced Malignancies [Phase 1]
Phase 1 study of TPI-287 in patients with advanced malignancies has completed, evaluating safety and preliminary activity in Non-Hodgkin lym…
-
CLINICAL_TRIALS trial_result · 2009-03-25Clinical Trial Update: Long-Term Follow-up of Tandem High-Dose Therapy With Peripheral Blood Stem Cell for Adults With High-Risk Age-Adjusted IPI Aggressive Non-Hodgkin's Lymphomas [Phase 2]
Long-term follow-up results from a Phase 2 trial evaluating tandem high-dose chemotherapy with autologous peripheral blood stem cell rescue …
-
CLINICAL_TRIALS trial_result · 2009-03-20Clinical Trial Update: HDS Plus PBPC Transplant Vs 4 More Courses of FrontLine Therapy in Pts With Aggressive NHL in PR After Induction Therapy [Phase 3]
Phase 3 trial comparing HDS plus peripheral blood progenitor cell transplant to additional FrontLine therapy in patients with aggressive non…
-
CLINICAL_TRIALS research · 2009-03-12Clinical Trial Update: Health and Psychosocial Outcomes in Long-Term Lymphoma Survivors
This clinical trial update reports on health and psychosocial outcomes in people who have survived lymphoma over the long term.
-
CLINICAL_TRIALS trial_result · 2009-03-04Clinical Trial Update: Safety of Soluble Beta-Glucan (SBG) in Treatment of Patients With Non-Hodgkin's Lymphoma [Phase 1]
Phase 1 trial evaluating the safety of Soluble Beta-Glucan in patients with Non-Hodgkin lymphoma has been completed.
-
CLINICAL_TRIALS trial_result · 2009-02-24Clinical Trial Update: CT-322 in Treating Patients With Advanced Solid Tumors and Non-Hodgkin's Lymphoma [Phase 1]
Phase 1 trial of CT-322 in patients with advanced solid tumors and non-Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2009-02-23Clinical Trial Update: Ciclophosphamide, Vincristine, Myocet and Prednisone, With Rituximab in 1st-Line Treatment for Patients With No-Hodgkin B Lymphoma and Cardiovascular (CV) Risk [Phase 2]
A Phase 2 clinical trial evaluating a first-line regimen of cyclophosphamide, vincristine, liposomal doxorubicin (Myocet), prednisone, and r…
-
CLINICAL_TRIALS trial_result · 2009-02-03Clinical Trial Update: Adjuvant Low Dose Total Body Irradiation in Elderly Patients With Diffuse Large B-Cell Lymphoma [Phase 2]
This report notes the completion of a Phase 2 trial evaluating adjuvant low-dose total body irradiation in elderly patients with diffuse lar…